NEOPLAMS
Clinical trials for NEOPLAMS explained in plain language.
Never miss a new study
Get alerted when new NEOPLAMS trials appear
Sign up with your email to follow new studies for NEOPLAMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cancer drug SIG001 enters first human tests
Disease control Not yet recruitingThis early-phase study tests a new drug called SIG001 in 66 people with advanced solid tumors that have not responded to standard treatments. The main goals are to check the drug's safety, find the best dose for future studies, and see if it helps shrink tumors. Participants rece…
Matched conditions: NEOPLAMS
Phase: PHASE1 • Sponsor: Peking University • Aim: Disease control
Last updated May 13, 2026 16:00 UTC
-
Jumping for joy: new exercise study aims to boost breast cancer recovery
Symptom relief Not yet recruitingThis study compares a plyometric (jumping) strength-endurance exercise program with standard strength training in 51 women who are breast cancer survivors or currently in treatment. The goal is to see if the plyometric program improves quality of life, physical function, and ment…
Matched conditions: NEOPLAMS
Phase: NA • Sponsor: University of Vigo • Aim: Symptom relief
Last updated May 15, 2026 11:56 UTC